Syros Pharmaceuticals (SYRS) Stock Chart & Stock Price History → Red Alert: Your Money's Disappearance Act - Banks' Greed Unleashed! (From Priority Gold) (Ad) Free SYRS Stock Alerts $5.57 +0.12 (+2.20%) (As of 12:32 PM ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability Syros Pharmaceuticals Stock Price Performance5 Day Performance+1.09%1 Month Performance+22.69%3 Month Performance-25.23%6 Month Performance+94.08%Year-To-Date Performance-28.50%1 Year Performance+39.25% Receive SYRS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Syros Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Wall Street StarThis Apple-like Innovator is Revolutionizing HealthcareAI has infiltrated so many sectors, it's sent the demand for AI-friendly GPU computer chips rocketing. Nvidia has gone up more than 3x in the past year. It is now valued well over $2 trillion, making it one of the largest companies in the world.Click here to learn more about the booming eHealth industry SYRS Stock Chart for Monday, May, 20, 2024 SYRS Chart by TradingView Syros Pharmaceuticals Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/17/2024$5.48$5.45-0.55%$5.52$5.29163,176 shs$145.68 million05/16/2024$5.51$5.48-0.54%$5.61$5.3641,273 shs$146.48 million05/15/2024$5.43$5.51+1.47%$5.86$5.36169,241 shs$147.28 million05/14/2024$5.06$5.43+7.31%$5.56$5.12187,271 shs$145.13 million05/13/2024$4.97$5.06+1.81%$5.16$4.9491,740 shs$135.25 million05/10/2024$5.01$4.97-0.80%$5.10$4.93139,469 shs$132.84 million Get the Latest News and Ratings for SYRS and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Syros Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 05/09/2024$5.00$5.01+0.20%$5.30$5.0088,047 shs$133.91 million05/08/2024$5.15$5.00-2.91%$5.15$4.9075,114 shs$133.65 million05/07/2024$5.08$5.15+1.38%$5.32$5.06105,550 shs$137.66 million05/06/2024$5.13$5.08-0.97%$5.21$5.0737,546 shs$135.79 million05/03/2024$5.20$5.13-1.35%$5.34$5.0595,319 shs$137.13 million05/02/2024$5.44$5.20-4.41%$5.64$5.19301,209 shs$139.00 million05/01/2024$5.40$5.44+0.74%$5.65$5.28199,560 shs$145.41 million04/30/2024$5.38$5.40+0.37%$5.43$5.2394,729 shs$144.34 million04/29/2024$5.04$5.38+6.75%$5.46$5.05113,590 shs$143.80 million04/26/2024$5.10$5.04-1.18%$5.12$4.9944,534 shs$134.72 million04/25/2024$5.07$5.10+0.59%$5.15$4.92128,568 shs$136.32 million04/24/2024$5.14$5.07-1.36%$5.20$5.0089,634 shs$135.52 million04/23/2024$4.99$5.14+3.01%$5.32$4.98172,666 shs$137.39 million04/22/2024$4.54$4.99+9.91%$5.03$4.57151,952 shs$133.38 million04/19/2024$4.72$4.54-3.81%$4.71$4.41262,896 shs$121.35 million04/18/2024$5.11$4.72-7.63%$5.06$4.72119,221 shs$126.17 million04/17/2024$5.56$5.11-8.09%$5.67$5.09125,722 shs$136.59 million04/16/2024$5.35$5.56+3.93%$5.76$5.18287,306 shs$147.06 million04/15/2024$5.39$5.35-0.74%$5.63$5.24148,071 shs$141.53 million04/12/2024$5.92$5.39-8.95%$5.95$5.33210,645 shs$142.57 million04/11/2024$5.53$5.92+7.05%$5.94$5.48258,089 shs$156.61 million04/10/2024$5.50$5.53+0.55%$5.62$5.21238,188 shs$146.29 million04/09/2024$4.50$5.50+22.22%$5.84$4.70991,107 shs$145.48 million04/08/2024$4.67$4.50-3.64%$4.70$4.50155,108 shs$119.03 million04/05/2024$4.82$4.67-3.11%$4.85$4.66129,574 shs$123.52 million04/04/2024$4.98$4.82-3.21%$5.17$4.73296,102 shs$127.49 million04/03/2024$4.64$4.98+7.44%$5.03$4.63430,399 shs$131.72 million04/02/2024$5.04$4.64-8.04%$5.02$4.55404,517 shs$122.60 million04/01/2024$5.35$5.04-5.79%$5.35$4.70355,438 shs$133.31 million03/29/2024$5.35$5.35$5.90$5.15318,254 shs$112.72 million03/28/2024$5.84$5.35-8.39%$5.90$5.15318,061 shs$112.72 million03/27/2024$6.25$5.84-6.56%$6.18$5.44431,796 shs$123.05 million03/26/2024$6.40$6.25-2.34%$6.47$6.22108,945 shs$131.69 million03/25/2024$6.27$6.40+2.07%$6.49$6.25156,006 shs$132.09 millionCEO of Biggest AI Chipmaker Just Dropped a Bombshell… (Ad)Nvidia’s CEO calls it the “next amazing revolution” … and even declared it “is going to be flat out of the biggest [revolution] ever.” Jeff Bezos, Bill Gates, and Mark Zuckerberg have invested billions in it.Click on Adam's shiny forehead for more details.03/22/2024$6.34$6.27-1.10%$6.34$6.2161,940 shs$132.11 million03/21/2024$6.33$6.34+0.16%$6.41$6.15107,069 shs$133.58 million03/20/2024$6.23$6.33+1.61%$6.38$5.9991,073 shs$133.37 million03/19/2024$6.10$6.23+2.13%$6.37$6.00128,839 shs$131.27 million03/18/2024$6.01$6.10+1.50%$6.23$5.99149,957 shs$128.53 million03/15/2024$6.03$6.01-0.33%$6.20$5.98222,457 shs$126.63 million03/14/2024$6.47$6.03-6.80%$6.49$5.85209,036 shs$127.05 million03/13/2024$6.46$6.47+0.15%$6.68$6.4173,821 shs$136.32 million03/12/2024$6.56$6.46-1.52%$6.59$6.4388,928 shs$136.11 million03/11/2024$6.77$6.56-3.10%$6.85$6.51101,899 shs$138.20 million03/08/2024$6.93$6.77-2.31%$7.27$6.75133,001 shs$142.64 million03/07/2024$7.13$6.93-2.81%$7.18$6.36346,090 shs$146.02 million03/06/2024$7.15$7.13-0.28%$7.25$7.09127,228 shs$150.23 million03/05/2024$7.60$7.15-5.92%$7.60$7.04279,967 shs$150.65 million03/04/2024$7.75$7.60-1.94%$7.90$7.41219,733 shs$160.13 million03/01/2024$7.26$7.75+6.75%$7.90$7.31415,371 shs$163.29 million02/29/2024$7.19$7.26+0.97%$7.51$7.11267,258 shs$152.97 million02/28/2024$7.34$7.19-2.04%$7.49$7.10295,710 shs$151.49 million02/27/2024$7.49$7.34-2.00%$7.96$7.04345,869 shs$154.65 million02/26/2024$7.26$7.49+3.17%$7.64$7.22153,201 shs$157.79 million02/23/2024$7.09$7.26+2.40%$7.66$6.96239,929 shs$152.97 million02/22/2024$7.04$7.09+0.71%$7.17$6.8275,674 shs$149.39 million02/21/2024$7.45$7.04-5.50%$7.62$6.82140,173 shs$148.33 million02/20/2024$7.18$7.45+3.76%$7.69$7.18169,525 shs$156.97 million02/19/2024$7.18$7.18$7.41$6.95170,900 shs$151.28 million Related Companies: INCR Stock Price Chart RENB Stock Price Chart IMAB Stock Price Chart SKYE Stock Price Chart SGMT Stock Price Chart CYBN Stock Price Chart RAPT Stock Price Chart CTMX Stock Price Chart CRVO Stock Price Chart RGLS Stock Price Chart Receive SYRS Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Syros Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:SYRS) was last updated on 5/20/2024 by MarketBeat.com Staff From Our PartnersElon to Transform U.S. Economy? Porter & CompanyRed Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Priority Gold"The Biggest Drug Ever" Is ComingBehind the MarketsMost important medical advance in 100 yearsThe Oxford ClubDoes this make you sick?Allegiance GoldThe Overlooked Retirement Asset You Probably Don’t OwnCrypto 101 MediaCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingThis Apple-like Innovator is Revolutionizing HealthcareWall Street Star Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Syros Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.